ONC – beone medicines ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26
BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Citizens Highlights BeOne Medicines' (ONC) $3.8B Revenue Potential for 2025 [Yahoo! Finance]
BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference
BeOne Medicines (NASDAQ:ONC) was upgraded by analysts at Sanford C. Bernstein to an "outperform" rating.
Form 4 BeOne Medicines Ltd. For: Feb 04 Filed by: Lee Chan Henry
Form 4 BeOne Medicines Ltd. For: Jan 07 Filed by: Lee Chan Henry
Form 4 BeOne Medicines Ltd. For: Dec 31 Filed by: Wang Lai
Form 4 BeOne Medicines Ltd. For: Dec 15 Filed by: OYLER JOHN
Form 4 BeOne Medicines Ltd. For: Dec 10 Filed by: Lee Chan Henry
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.